Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KMT2CP2, or Lysine methyltransferase 2C pseudogene 2, is a non-functional DNA sequence classified as a pseudogene. It resembles the functional gene KMT2C, which encodes the histone methyltransferase enzyme MLL3. Pseudogenes like KMT2CP2 are not translated into functional proteins and are not targets for pharmacological intervention. Distinct from the functional KMT2C gene, KMT2CP2 has no established role in epigenetic regulation, development, or disease. All molecular functions, disease associations, and drug interactions listed for KMT2C/MLL3 do not apply to KMT2CP2[1][3][4][5][7].\n\nKMT2CP2 is a nucleic acid sequence deemed non-functional and not a pharmacological or research target. References to biological activities, molecular function, disease involvement, or drug targeting exclusively relate to KMT2C/MLL3, the functional gene/protein, and should not be attributed to the pseudogene KMT2CP2[1][3][4][5][7].
None (as no drugs interact with this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine methyltransferase 2C pseudogene 2 (KMT2CP2).